LSB   $3.08  -2.22% Market Closed

LakeShore Biopharma Co Ltd
Total Cash 246.35M
totalCashPerShare 12.911
EBITDA -315.90M
Total Debt 424.46M
quickRatio 0.864
currentRatio 1.126
Total Revenue 573.42M
debtToEquity 72.532
Revenue/Share 53.629
ROA -0.13846
ROE -0.65993
grossProfits
freeCashflow -216.49M
operatingCashflow -295.23M
earningsGrowth
revenueGrowth 0.277
grossMargins 0.67326
ebitdaMargins -0.55091
operatingMargins -0.68832
profitMargins -0.75593
enterpriseValue 219.33M
forwardPE
floatShares 3.60M
sharesOutstanding 19.08M
sharesShort 7.96K
sharesShortPriorMonth 2.84K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.81%
heldPercentInstitutions 0.03%
Short Ratio help_outline 0.25%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 30.763
Price To Book help_outline 0.07
earningsQuarterlyGrowth
netIncomeToCommon -433.46M
trailingEps -5.69%
forwardEps -0.25%
enterpriseToEbitda -0.69
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.95 2Q 2024
institutionsCount 11
lastUpdated Nov. 2, 2024, 7:38 a.m.